CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale CEO sold 50,000 shares at an average $23.77 ($1,188,745)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Finance and Treasurer sold 187 shares at $24.41 ($4,565)
- 4 Gift President gave 123,407 shares (gift)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Medical Officer sold 16,667 shares at $25.74 ($429,037)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 373 shares at $34.73 ($12,954)
- 4 Planned sale CEO sold 50,000 shares at an average $34.90 ($1,745,037)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 284,860 shares at an average $35.24 ($10,039,492)
- 4 Option exercise President acquired 35,505 shares (option exercise)
- 8-K Event Shareholder vote results
Page 1 of 26 · 514 filings